Medicine-Based Evidence in Congenital Heart Disease: How Artificial Intelligence Can Guide Treatment Decisions for Individual Patients
Built on the foundation of the randomized controlled trial (RCT), Evidence Based Medicine (EBM) is at its best when optimizing outcomes for homogeneous cohorts of patients like those participating in an RCT. Its weakness is a failure to resolve a clinical quandary: patients appear for care individua...
Saved in:
Main Authors: | Jef Van den Eynde, Cedric Manlhiot, Alexander Van De Bruaene, Gerhard-Paul Diller, Alejandro F. Frangi, Werner Budts, Shelby Kutty |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/4a91857ed8d5485e89f290738d055af5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Left ventricular vortex analysis by high-frame rate blood speckle tracking echocardiography in healthy children and in congenital heart disease
by: Pietro Marchese, et al.
Published: (2021) -
Pain in adults with congenital heart disease - An international perspective
by: Allison Leibold, et al.
Published: (2021) -
How to read a published clinical trial: a practical guide for clinicians
by: Mohamad B Sonbol, et al.
Published: (2020) -
Frequency, Mortality, and Predictors of Adverse Outcomes for Endocarditis in Patients with Congenital Heart Disease: Results of a Nationwide Analysis including 2512 Endocarditis Cases
by: Maarja Maser, et al.
Published: (2021) -
Trials
Published: (2006)